ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

FDBK Feedback Plc

97.50
0.00 (0.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Feedback Plc LSE:FDBK London Ordinary Share GB00BJN59X09 ORD 50P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 97.50 95.00 100.00 97.50 97.50 97.50 5,188 07:36:53
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Electronic Computers 1.03M -2.92M -0.2188 -4.46 13M
Feedback Plc is listed in the Electronic Computers sector of the London Stock Exchange with ticker FDBK. The last closing price for Feedback was 97.50p. Over the last year, Feedback shares have traded in a share price range of 58.00p to 150.00p.

Feedback currently has 13,334,659 shares in issue. The market capitalisation of Feedback is £13 million. Feedback has a price to earnings ratio (PE ratio) of -4.46.

Feedback Share Discussion Threads

Showing 13101 to 13124 of 14800 messages
Chat Pages: Latest  532  531  530  529  528  527  526  525  524  523  522  521  Older
DateSubjectAuthorDiscuss
25/2/2022
13:56
This Institution of Engineering and Technology (IET) report sets out our position on the digital transformation of the National Health Service (NHS) and social care across England. While the NHS has faced and met the greatest challenge of its 73-year history in the Covid-19 pandemic, preparatory work has continued towards the long-term goal of ensuring widespread interoperability across the sector..https://www.theiet.org/media/9617/the-digital-advantage.pdf
ragnarr
25/2/2022
09:55
Just dropped by to see how Captain Tom's pension scheme was going. It seems it's doing quite well for him despite the usual lack of anyone actually wanting to buy his transformational product offering. Unbelievable..
davwal
23/2/2022
20:39
Yump, I would love to have something to ramp! Every RNS makes me cringe.
The claim that TO held a certain percentage of the stock! Absolutely misleading, the %age was his options, he has not, to this date invested a penny in the company, despite earning more than the prime minister.
His cringeworthy video interview proclaiming a 9% increase in revenue! Oh Lord.
£10b addressable revenue! Embarrassing.
I do continue to hold as I do believe the potential is very good but oh my word it is hard work.
These Clowns will really have to deliver solid revenue before the market reacts.
Here’s hoping!

ducatiman
23/2/2022
17:02
Courtesy of Vascular over on LSE - position now closedhttps://uk.trabajo.org/job-1268-20220219-96d28def35503b9114cc34b115127167?r=YToyOntzOjQ6InBhZ2UiO2k6MTtzOjc6ImtleXdvcmQiO3M6NjoiYmxlZXBhIjt9PLEASE NOTE: INTERNAL APPLICANTS ONLYBand 7 Chief Medical PhotographerDue to retirement of the Chief Medical Photographer, we have a need to appoint a leader of the Medical Photography Department (MPD) at Royal Berkshire NHS FT. MPD is part of Medical Physics and Clinical Engineering (MPCE) within the Berkshire Cancer Centre and provides a trust-wide photography service. This includes c.3000 clinical patient photographs per annum in addition to specialist clinics in departments such as ophthalmology.The department undertakes numerous projects including production of films and videos and other reprographics for promotional and educational purposes.MPD also provides expertise and guidance in introducing new technologies and applications such as Bleepa to facilitate the safe capture and sharing of images taken by clinical staff, including establishing protocols for patient consent, etc.The Chief Photographer will lead and develop this team, identifying and implementing opportunities to transform and improve the service, and will play a part of the management team within MPCE .
ragnarr
23/2/2022
15:25
Uncritical regulars and rampers ?

Posting on the wrong thread I think.

Challenge:
Find a ramper here.

Good luck with that.

yump
23/2/2022
15:12
Why not Duc, I've seen plenty of other companies do similar? More convinced than ever that we will have plenty of good news in the next two months.
lr2
23/2/2022
14:19
LR2 - more than likely but yet another kick in the gonads for us plebs under the guise of our supposedly benefitting from any good news as well as them.
digger2779
23/2/2022
13:54
Are they allowed to do that LR2?
ducatiman
23/2/2022
13:40
News soon then now the options have been granted.
lr2
23/2/2022
11:21
At least something is ahead of expectations.
orange1
23/2/2022
09:49
These option awards are certainly ahead of expectations
photon
23/2/2022
08:20
held this puppy too long
middlesboroughfc
23/2/2022
08:19
Tom getting more options for delivering zero.
1bond
23/2/2022
08:05
Performance related options mind. But sadly the vesting conditions are related to the company's share price rather than how the company's business is doing.
orange1
23/2/2022
07:27
Quite often directors will buy shares to support the share price if they feel the market is undervaluing their company.
Here it would seem they take advantage of a weak share price by granting options.

ducatiman
19/2/2022
19:35
Just wish ydderF would go post on the IQAI board instead of here. Talk about holding a grudge.
lr2
19/2/2022
19:23
Just wish fybberF could afford to buy Texrad.
ducatiman
19/2/2022
19:07
TexRAD still in use.

Diagnostic performance of CT lung severity score and quantitative chest CT for stratification of COVID-19 patients



'Texture analysis was performed by using a dedicated software (TexRAD, Feedback Medical Ltd., Cambridge, UK). Statistical analysis was performed using MedCalc Statistical Software version 17.9.7 (MedCalc Software bvba, Ostend, Belgium).'

lr2
19/2/2022
18:47
Raising £11.2m no mean feat. Walter Mithof or entrepreneurial genius?
We still don’t know but it won’t be too long now.
If the latter I doubt we will hear from fybberF again.

ducatiman
19/2/2022
08:56
LR2 and other uncritical regulars here, Buywell is pointing out the lack of progress in ten years. Though the facts speak for themselves, anyone newly coming to this cosy club of uncritical supporters should be able to make their minds up from a balanced mix of views. Fact is the reams of positive posts with any basis over the years (see the chart) have self-evidently been fantasy.

The most successful operation the Company has executed has been to raise millions with the continuous issue of huge numbers of shares.

Here is a simple question to you LR2, as a shareholder. How has it benefited your net worth in this investment over the years that this has happened?

...and a second simple question, who has benefitted?

One thing all objective holders can agree upon is that it has been an utterly appalling investment for anyone buying in any one of the last 10 years, quite shocking

ydderf
18/2/2022
21:27
So Buywell, with no interest in this company, why are you hanging around this board?
lr2
18/2/2022
20:42
Too much ramping on next to nothing sales imo

Reminds buywell of another share that was tipped for NHS bigtime take-up

Attracted a star fund manager at the time that bought a big holding --- and a potential USA partner

But the NHS never moved and the share price slid till it delisted


free stock charts from uk.advfn.com

buywell3
18/2/2022
18:07
Courtesy of Vascular on the other place.



I'd have hoped Bleepa would have had a Database Developer when it was first being developed. Maybe it's for a replacement developer. Used to love designing databases in the dim and distant past. Very satisfying.

lr2
18/2/2022
13:37
Condolences, and commiserations...
ydderf
Chat Pages: Latest  532  531  530  529  528  527  526  525  524  523  522  521  Older

Your Recent History

Delayed Upgrade Clock